Lymph and blood vessel architecture in benign and malignant prostatic tissue: lack of lymphangiogenesis in prostate carcinoma assessed with novel lymphatic marker lymphatic vessel endothelial hyaluronan receptor (LYVE-1). (The Journal of urology, 2004)

(untitled) - Trojan, L; Michel, MS; Rensch, F; Jackson, D; Alken, P; Grobholz, R